The same low dose of VIP (0.5 nmol/ mouse) was chosen for our murine study as VIP in higher doses (1 and 5 nmol/ mouse) failed to provide beneficial impact on C. rodentium infection induced colitis due to downregulation of receptors [34]. This evidence concerns the gene VIP and colitis.